Mammalian cytotoxicity assay

RC Ryan Choi
MZ Mowei Zhou
RS Roger Shek
JW Jesse W. Wilson
LT Logan Tillery
JC Justin K. Craig
IS Indraneel A. Salukhe
SH Sarah E. Hickson
NK Neeraj Kumar
RJ Rhema M. James
GB Garry W. Buchko
RW Ruilian Wu
SH Sydney Huff
TN Tu-Trinh Nguyen
BH Brett L. Hurst
SC Sara Cherry
LB Lynn K. Barrett
JH Jennifer L. Hyde
WV Wesley C. Van Voorhis
request Request a Protocol
ask Ask a question
Favorite

Lead compounds were tested in vitro against two mammalian cell lines to evaluate cytotoxicity. CRL-8155 human lymphocyte and HepG2 human hepatocyte cells (ATCC, Manassas, VA) were seeded in 96-well plates and incubated at 37°C for 48 h in the presence of test compound (serial-2 dilutions, in triplicate). At the end of the incubation period, cells were visually assessed before alamarBlueTM (Thermo Fisher, Waltham, MA), a resazurin-based cell viability reagent which measures metabolic activity, was added to the plates and fluorescence measured on a BioTek FLx-800 microplate reader (BioTek Instruments, Winooski, VT). Fluorescence signals resulting from cell viability changes were compared with control wells to calculate 50% cytotoxic concentrations (CC50) values.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A